Capital expenditure · 2015–2025
GSK capital expenditure
$1.8B−0.6% · FY2025
GSK (GSK) reported $1.8B in capital expenditure for fiscal 2025, −0.6% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.8B | −0.6% | Open → |
| FY20242024-12-31 | $1.8B | +9.5% | Open → |
| FY20232023-12-31 | $1.6B | +15.7% | Open → |
| FY20222022-12-31 | $1.4B | +8.0% | Open → |
| FY20212021-12-31 | $1.3B | +2.9% | Open → |
| FY20202020-12-31 | $1.3B | −21.3% | Open → |
| FY20192019-12-31 | $1.6B | −10.1% | Open → |
| FY20182018-12-31 | $1.8B | −9.9% | Open → |
| FY20172017-12-31 | $2.0B | −4.5% | Open → |
| FY20162016-12-31 | $2.1B | −1.2% | Open → |
| FY20152015-12-31 | $2.1B | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth −1.7%
Figures are reported under IFRS in GBP and converted to US dollars at ECB reference rates — fiscal 2025 average 0.758 GBP/$ for income items, year-end 0.743 GBP/$ for balance-sheet items.
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=GSK capital expenditure |url=https://companiesranked.com/en/company/gsk/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). GSK capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/gsk/capital-expenditureBibTeX
@misc{companiesranked-en-company-gsk-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{GSK capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/gsk/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001131399-26-000004 · March 6, 2026
{{cite web |title=GSK capital expenditure — 20-F (0001131399-26-000004) |url=https://www.sec.gov/Archives/edgar/data/1131399/000113139926000004/gsk-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.